Related Experiment Videos
Tricuspid valve replacement in rheumatic heart disease
British Medical Journal
|September 12, 1970
Summary
Diagnosing tricuspid valve disease is challenging, and optimal treatment remains unclear. Tricuspid valve replacement in twenty patients resulted in a 25% mortality rate, often linked to cardiac complications and preoperative cachexia.
Area of Science:
- Cardiology
- Cardiac Surgery
- Valvular Heart Disease
Background:
- Tricuspid valve disease diagnosis presents significant challenges.
- Established optimal treatment strategies for tricuspid valve disease are lacking.
Purpose of the Study:
- To evaluate the outcomes of tricuspid valve replacement surgery.
- To identify factors influencing mortality and survival in patients undergoing tricuspid valve replacement.
Main Methods:
- Retrospective analysis of twenty patients undergoing tricuspid valve replacement.
- Procedures were performed as part of multiple valve replacement surgeries at St. Thomas's Hospital.
Main Results:
- Hospital mortality rate was 25%.
- Low cardiac output leading to hepatorenal failure was the primary cause of death.
- Preoperative cardiac cachexia was associated with a fatal outcome in all affected patients.
- Surviving patients generally achieved a satisfactory level of activity.
Conclusions:
- Tricuspid valve replacement carries a significant hospital mortality risk.
- Preoperative cardiac cachexia is a critical negative prognostic factor.
- Careful patient selection and management are crucial for improving outcomes in tricuspid valve surgery.